Gout, Hyperuricemia, and the Risk of Cardiovascular Disease: Cause and Effect?
- 670 Downloads
Gout and hyperuricemia have long been suspected to be risk factors for cardiovascular disease. However, studies have frequently failed to distinguish whether these entities have an independent effect on cardiovascular risk or serve as markers for other risk factors. In vitro and animal studies suggest that uric acid is a biologically active compound that can increase inflammatory mediators known to lead to vascular damage. In contrast, uric acid also has potentially protective effects as a strong antioxidant, approaching the potency of vitamin C. Large clinical trials demonstrate a consistent relationship between elevated serum uric acid and a variety of cardiovascular diseases, although the strength of association varies greatly. We review the evidence for and against an independent role for hyperuricemia and/or gout in cardiovascular pathology.
KeywordsGout Hyperuricemia Cardiovascular disease Inflammation
The authors wish to thank Dr. Michael Pillinger for use of the figure.
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 4.• Hahn BH, Grossman J, Chen W, McMahon M: The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007, 28:69–75. This is a good review on how autoimmune rheumatic diseases play a role in accelerated or premature atherosclerosis.Google Scholar
- 12.Cheng TH, Lin JW, Chao HH, et al.: Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 2008 Oct 20 (Epub ahead of print).Google Scholar
- 18.Martinez-Hervas S, Real JT, Ivorra C, et al.: Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis 2009 Sep 16 (Epub ahead of print).Google Scholar
- 38.Ioachimescu AG, Brennan DM, Hoar BM, et al.: Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008, 58:623–630.CrossRefPubMedGoogle Scholar
- 43.• Kuo CF, See LC, Luo SF, et al.: Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 2010, 49:141–146. This is one of the most recent and largest population-based studies evaluating the association between hyperuricemia and CVD.Google Scholar
- 44.Stamler J, Wentworth D, Neaton JD: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986, 256:2823–2828.CrossRefPubMedGoogle Scholar
- 49.Doehner W, Schoene N, Rauchhaus M, et al.: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002, 105:2619–2624.CrossRefPubMedGoogle Scholar